Cellevolve Bio
San Francisco-based cell therapy provider, partnering with global innovators to advance and commercialize novel therapeutics.
Founded
2020San Francisco-based cell therapy provider, partnering with global innovators to advance and commercialize novel therapeutics.
Cellevolve Bio, founded in San Francisco, is dedicated to revolutionizing health outcomes through the development and commercialization of novel cell therapies. The company partners with global innovators to advance clinical-stage therapies, particularly focusing on neglected diseases. By leveraging technological advances and a collaborative approach, Cellevolve aims to bring innovative treatments from late-stage development to market, addressing unmet medical needs and transforming patient care.
Notable affiliated individuals and investors include leaders and experts in biotechnology and healthcare, though specific names are not provided. Key achievements of Cellevolve Bio include establishing strategic partnerships with academic centers and biotech firms worldwide, driving the advancement of cutting-edge cell therapies. The company's impact lies in its commitment to democratizing innovation and improving health outcomes for patients with diseases that have been historically overlooked.
Companies similar to Cellevolve Bio include ElevateBio, Cell BioEngines, Cellular Approaches and Celularity.
Cellevolve Bio was founded in 2020.
Cellevolve Bio's headquarters is located in San Francisco, CA, US.
Cellevolve Bio's most recent funding round was for $6M (USD) in November 2021.
As of Nov 18, 2021, Cellevolve Bio has disclosed funding of $6M (USD). Undisclosed round amounts are excluded.
Cellevolve Bio has 9 employees as of Feb 4, 2024.
Celularity
celularity.com
